Voiceitt for People With Impairments in Speech

NCT ID: NCT06874322

Last Updated: 2025-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-25

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions like CP, ALS, Stroke or Parkinson's disease, etc., cause communication impairment. There are few augmentative communication options that allow people with these impairments to communicate effectively.

Voiceitt is an app that is designed to assist people with speech impairments by using a voice recognition and dictation tool that adapts to users' unique, non-standard speech patterns. However, its effectiveness in clinical populations has not been established. This study is bridging the gap in evaluating the preliminary effectiveness and feasibility of Voiceitt app in improving communication among people with mild to moderate speech impairments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Speech Impairment Speech Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Voiceitt

Participants will use Voiceitt App. Voiceitt is a voice recognition and dictation tool that adapts to users' unique, non-standard speech patterns. It integrates with mainstream devices and platforms to enable communication, accessibility, and independence for people with speech disabilities. https://www.voiceitt.com/

Group Type EXPERIMENTAL

Voiceitt

Intervention Type OTHER

Participants will use Voiceitt App

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Voiceitt

Participants will use Voiceitt App

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 13 or older
* moderately severe speech dysarthria due to conditions such as CP, stroke, ALS or Parkinson's Disease, etc.
* Ability to understand and follow instructions for using the Voiceitt app.

Exclusion Criteria

* Severe cognitive impairments that prevent the understanding of the Voiceitt app and required training.
* Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia.
* Severe physical impairments that prevent interaction with the app.
* Non-English speakers.
Minimum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duquesne University

OTHER

Sponsor Role collaborator

University of Pittsburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Brad Dicianno

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brad E Dicianno, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center for Assistive Technology

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Brad E Dicianno, MD

Role: CONTACT

(412) 648-6666

Zara Ambadar, Ph.D

Role: CONTACT

4126086118

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Katya Hill, PhD, CCC-SLP

Role: primary

412-383-6659

Brad E Dicianno, MD

Role: backup

(412) 648-6666

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY24100164

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Voice Telerehabilitation
NCT05747859 COMPLETED